Boston Therapeutics, Inc. Stock Other OTC
Equities
BTHE
US1011501004
Advanced Medical Equipment & Technology
Sales 2021 | 142K 194K | Sales 2022 | 15.45K 21.11K | Capitalization | 9.32M 12.73M |
---|---|---|---|---|---|
Net income 2021 | -9M -12.3M | Net income 2022 | -12M -16.4M | EV / Sales 2021 | 149 x |
Net Debt 2021 | 4.52M 6.17M | Net Debt 2022 | 11.39M 15.56M | EV / Sales 2022 | 1,340 x |
P/E ratio 2021 |
-1.75
x | P/E ratio 2022 |
-0.62
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 42.05% |
Managers | Title | Age | Since |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 23-01-18 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
1st Jan change | Capi. | |
---|---|---|
+4.79% | 32.47B | |
+16.51% | 7.45B | |
+23.49% | 3.89B | |
-15.71% | 3.17B | |
-27.53% | 1.28B | |
-33.58% | 1.09B | |
-33.74% | 902M | |
+0.98% | 893M | |
-25.64% | 857M |